Omnicell (OMCL) Cash & Equivalents (2010 - 2026)

Omnicell (OMCL) has 17 years of Cash & Equivalents data on file, last reported at $174.9 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $174.9 million, down 54.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.9 million (down 54.79% YoY), and the FY2025 annual result was $196.5 million, down 46.77% from the prior year.
• Cash & Equivalents declined to $174.9 million in Q1 2026 per OMCL's latest filing, from $196.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $570.6 million in Q3 2024 and troughed at $174.9 million in Q1 2026.
• A 5-year average of $359.3 million and a median of $369.2 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents soared 67.73% in 2023, then sank 68.44% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $330.4 million in 2022, then jumped by 41.65% to $468.0 million in 2023, then declined by 21.11% to $369.2 million in 2024, then tumbled by 46.77% to $196.5 million in 2025, then fell by 11.0% to $174.9 million in 2026.
• Business Quant data shows OMCL's Cash & Equivalents at $174.9 million in Q1 2026, $196.5 million in Q4 2025, and $180.1 million in Q3 2025.